38 related articles for article (PubMed ID: 7579355)
1. Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis.
Hwang HC; Martins CP; Bronkhorst Y; Randel E; Berns A; Fero M; Clurman BE
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11293-8. PubMed ID: 12151601
[TBL] [Abstract][Full Text] [Related]
2. Truncated protein tyrosine phosphatase receptor type O suppresses AKT signaling through IQ motif containing GTPase activating protein 1 and confers sensitivity to bortezomib in multiple myeloma.
Wang H; Baladandayuthapani V; Wang Z; Lin H; Berkova Z; Davis RE; Yang L; Orlowski RZ
Oncotarget; 2017 Dec; 8(69):113858-113873. PubMed ID: 29371952
[TBL] [Abstract][Full Text] [Related]
3. Genetic aberrations in childhood acute lymphoblastic leukaemia: application of high-density single nucleotide polymorphism array.
Sulong S
Malays J Med Sci; 2010 Jul; 17(3):5-12. PubMed ID: 22135543
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer.
Tapia C; Zlobec I; Schneider S; Kilic E; Güth U; Bubendorf L; Kim S
Hum Pathol; 2011 Jul; 42(7):983-90. PubMed ID: 21315418
[TBL] [Abstract][Full Text] [Related]
5. A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer.
Kim S; Chin K; Gray JW; Bishop JM
Proc Natl Acad Sci U S A; 2004 Nov; 101(46):16251-6. PubMed ID: 15528276
[TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer.
Motiwala T; Kutay H; Ghoshal K; Bai S; Seimiya H; Tsuruo T; Suster S; Morrison C; Jacob ST
Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13844-9. PubMed ID: 15356345
[TBL] [Abstract][Full Text] [Related]
7. Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas.
Motiwala T; Ghoshal K; Das A; Majumder S; Weichenhan D; Wu YZ; Holman K; James SJ; Jacob ST; Plass C
Oncogene; 2003 Sep; 22(41):6319-31. PubMed ID: 14508512
[TBL] [Abstract][Full Text] [Related]
8. p27KIP1 deletions in childhood acute lymphoblastic leukemia.
Komuro H; Valentine MB; Rubnitz JE; Saito M; Raimondi SC; Carroll AJ; Yi T; Sherr CJ; Look AT
Neoplasia; 1999 Aug; 1(3):253-61. PubMed ID: 10935480
[TBL] [Abstract][Full Text] [Related]
9. TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1.
Fenrick R; Wang L; Nip J; Amann JM; Rooney RJ; Walker-Daniels J; Crawford HC; Hulboy DL; Kinch MS; Matrisian LM; Hiebert SW
Mol Cell Biol; 2000 Aug; 20(16):5828-39. PubMed ID: 10913166
[TBL] [Abstract][Full Text] [Related]
10. The p27/Kip1 locus shows no loss of heterozygosity in human pituitary adenomas.
Wilson JC; Zhu JJ; Black PM
J Neurooncol; 1999 Aug; 44(1):35-9. PubMed ID: 10582666
[No Abstract] [Full Text] [Related]
11. Fluorescence in situ hybridization analysis of 12;21 translocation in Japanese childhood acute lymphoblastic leukemia.
Eguchi-Ishimae M; Eguchi M; Tanaka K; Hamamoto K; Ohki M; Ueda K; Kamada N
Jpn J Cancer Res; 1998 Jul; 89(7):783-8. PubMed ID: 9738986
[TBL] [Abstract][Full Text] [Related]
12. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL.
Wang LC; Kuo F; Fujiwara Y; Gilliland DG; Golub TR; Orkin SH
EMBO J; 1997 Jul; 16(14):4374-83. PubMed ID: 9250681
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter.
Fears S; Gavin M; Zhang DE; Hetherington C; Ben-David Y; Rowley JD; Nucifora G
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1949-54. PubMed ID: 9050885
[TBL] [Abstract][Full Text] [Related]
14. Detection of minimal residual disease in multiple myeloma and acute leukaemia.
Bakkus MH; Juge-Morineau N; van der Werff ten Bosch JE
Med Oncol; 1996 Jun; 13(2):121-31. PubMed ID: 9013476
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity in the chromosomal region 12p12-13 is very common in childhood acute lymphoblastic leukemia and permits the precise localization of a tumor-suppressor gene distinct from p27KIP1.
Cavé H; Gérard B; Martin E; Guidal C; Devaux I; Weissenbach J; Elion J; Vilmer E; Grandchamp B
Blood; 1995 Nov; 86(10):3869-75. PubMed ID: 7579355
[TBL] [Abstract][Full Text] [Related]
16. Acute lymphoblastic leukemia of childhood: identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1.
Takeuchi S; Bartram CR; Miller CW; Reiter A; Seriu T; Zimmerann M; Schrappe M; Mori N; Slater J; Miyoshi I; Koeffler HP
Blood; 1996 Apr; 87(8):3368-74. PubMed ID: 8605354
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood.
Stegmaier K; Pendse S; Barker GF; Bray-Ward P; Ward DC; Montgomery KT; Krauter KS; Reynolds C; Sklar J; Donnelly M
Blood; 1995 Jul; 86(1):38-44. PubMed ID: 7795247
[TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter: evidence for two new tumour-suppressor genes.
Hatta Y; Takeuchi S; Yokota J; Koeffler HP
Br J Cancer; 1997; 75(9):1256-62. PubMed ID: 9155043
[TBL] [Abstract][Full Text] [Related]
19. Childhood acute lymphoblastic leukemia: is there a tumor suppressor gene in chromosome 12p12.3?
Aïssani B; Bonan C; Baccichet A; Sinnett D
Leuk Lymphoma; 1999 Jul; 34(3-4):231-9. PubMed ID: 10439360
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
